Shocking Study Reveals 40% of Liver Transplant Patients Unprotected Against Hepatitis B
A groundbreaking study just published in 'Clinical Infectious Diseases' reveals a troubling reality: a staggering 40% of liver transplant recipients in the United States remain unvaccinated against the Hepatitis B virus (HBV). This critical oversight leaves thousands of vulnerable patients exposed to severe and potentially fatal complications, including liver failure and cancer, despite clear clinical guidelines emphasizing pre-transplant immunization. The research, spearheaded by scientists from Baylor College of Medicine, analyzed data from over 13,000 deceased-donor liver transplant recipients between September 2022 and June 2024, highlighting significant gaps in current medical practices.

















